Various biomarkers are specifically expressed or overexpressed on the tumor cell surface, such as prostate specific membrane antigen (PSMA), which is overexpressed in most prostate cancer cells, and human epidermal growth factor receptor-2 (HER2), which is overexpressed in up to 30% of breast cancers [80]. This evidence concerns the gene FOLH1 and prostate carcinoma.